In a report released on January 21, Richard Chamberlain from RBC Capital maintained a Buy rating on Next plc (NXT – Research Report), with a ...

In a report released on January 20, Rishi Jaluria from RBC Capital maintained a Buy rating on Clearwater Analytics Holdings (CWAN – Research ...

RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, ...

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $14.55 which represents a slight increase of $0.42 or 2.97% from the prior close of $14.13. The stock opened at $14.3 and ...

Dyne Therapeutics Inc (DYN) stock saw a decline, ending the day at $14.13 which represents a decrease of $-0.64 or -4.33% from the prior close of $14.77. The stock opened at $14.89 and touched a low ...

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...

Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets ...

Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove ...

Hedge funds have positioned for Donald Trump's U.S. presidency with their highest levels of borrowing since 2010, while ...